The effect of multiflora honey from Southeastern Anatolia on pro-inflammatory and pro-apoptotic pathways in MDA-MB-231 cell line
Öz
Purpose: Honey is increasingly recognized for its medicinal and nutritional benefits, including its anti-bacterial, anti-inflammatory, antioxidant, anti-ulcer, and anti-tumor properties. This study aimed to evaluate the effects of Anatolian honey (Southeast Anatolia) on the expression of pro-apoptotic genes and chemotactic molecules in breast cancer cells.
Materials and Methods: The IC50 concentration of Anatolian honey, determined to be 2.7% (w/v) at 48 hours, was used for treatment. Gene expression analysis was performed using the SYBR Green quantitative reverse transcription polymerase chain reaction (qRT-PCR) technique.
Results: The expression levels of the pro-apoptotic genes Bax and Caspase-3 increased by 6.05-fold and 2.01-fold, respectively, while the chemotactic molecule CCL2 exhibited a 6.45-fold upregulation. In contrast, CCL5 and CX3CR1 showed minimal changes in expression, with fold changes of 1.04 and 1.11, respectively. Anatolian honey promoted apoptosis by increasing Bax and Cas3 expression. Additionally, the elevated CCL2 expression suggests a potential role in recruiting monocytes and facilitating their differentiation into macrophages within the tumor microenvironment.
Conclusion: Anatolian honey exhibits pro-apoptotic and immunomodulatory effects in breast cancer cells by upregulating Bax, Cas3, and CCL2 expression. These findings highlight its potential as a complementary therapeutic agent.
Anahtar Kelimeler
Destekleyen Kurum
TUBITAK
Proje Numarası
1919B012101193
Etik Beyan
Ethics Committee Approval is not necessary in this project, because this is an in vitro study including cell culture and it does not include any other human or animal materials.
Kaynakça
- Farcas CG, Dehelean C, Pinzaru IA, Mioc M, Socoliuc V, Moaca EA et al. Thermosensitive betulinic acid-loaded magnetoliposomes: a promising antitumor potential for highly aggressive human breast adenocarcinoma cells under hyperthermic conditions. Int J Nanomedicine. 2020;15:8175.
- Arumugam A, Din Ibrahim M, Kntayya SB, Ain NM, Iori R, Galletti S et al. Induction of apoptosis by gluconasturtiin-isothiocyanate (GNST-ITC) in human hepatocarcinoma HepG2 cells and human breast adenocarcinoma MCF-7 cells. Molecules. 2020;25:1240.
- Sanchez M, Barrere V, Treilleux I, Chopin N, Melodelima D. Development of a noninvasive HIFU treatment for breast adenocarcinomas using a toroidal transducer based on preliminary attenuation measurements. Ultrason Sonochem. 2021;115:106459.
- Eteraf-Oskouei T, Najafi M. Uses of natural honey in cancer: an updated review. Adv Pharm Bull. 2022;12:248–61.
- Qadirifard MS, Fathabadi A, Hajishah H, Gholami K, Abbasi M, Sami N et al. Anti-breast cancer potential of honey: a narrative review. OncoReview. 2022;12:5–15.
- Yaacob NS, Nengsih A, Norazmi MN. Tualang honey promotes apoptotic cell death induced by tamoxifen in breast cancer cell lines. eCAM. 2013; 2013:989841.
- Aryappalli P, Al-Qubaisi SS, Attoub S, George JA, Arafat K, Ramadi KB et al. The IL-6/STAT3 signaling pathway is an early target of Manuka honey-induced suppression of human breast cancer cells. Front Oncol. 2017;7:167.
- Qiu J, Xu L, Zeng X, Wu H, Liang F, Lv Q et al. CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells. Front Oncol. 2022;12:972383.
- Derossi DR, Amarante MK, Guembarovski RL, de Oliveira CEC, Suzuki KM, Watanabe MAE et al. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment. Mol Biol Rep. 2019;46:6165–170.
- Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15:335–45.
